Cochrane, M, Mitchell, E, Hollingworth, W et al. · Applied health economics and health policy · 2021 · DOI
This review looked at whether ME/CFS treatments are worth the money they cost. Researchers found that cognitive behavioral therapy (CBT)—a type of talking therapy—appears to be cost-effective for some adults with ME/CFS, though results varied depending on how it was delivered. There is much less evidence for other treatments, and very little research on what works best for children with ME/CFS.
This systematic review addresses a critical gap in ME/CFS care: understanding which treatments provide good value for patients and healthcare systems. With ME/CFS causing substantial disability and economic burden, evidence on cost-effective interventions helps patients, clinicians, and policymakers make informed decisions about resource allocation and treatment selection.
This review does not prove that CBT or GET are universally effective or safe for all ME/CFS patients—it only addresses cost-effectiveness in selected trial populations. The review cannot establish optimal treatment duration, frequency, or individual patient factors predicting who will benefit economically. The limited pediatric evidence means findings may not apply to children with ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Cochrane, M, Mitchell, E, Hollingworth, W, Crawley, E, & Trépel, D (2021). Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.. Applied health economics and health policy. https://doi.org/10.1007/s40258-021-00635-7
BibTeX
@article{mecfsatlas-cochrane-2021-cost-effectiveness,
author = {Cochrane, M and Mitchell, E and Hollingworth, W and Crawley, E and Trépel, D},
title = {Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.},
journal = {Applied health economics and health policy},
year = {2021},
doi = {10.1007/s40258-021-00635-7},
note = {PubMed: 33646528},
url = {https://www.mecfsatlas.com/evidence/cochrane-2021-cost-effectiveness},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-30. https://www.mecfsatlas.com/evidence/cochrane-2021-cost-effectiveness
Contribute
Private, reviewed by a human. Not a public comment thread.